BioCentury | Jan 24, 2020
Preclinical News

Jan. 23 Preclinical Quick Takes: Metastasis-associated cancer-associated fibroblast populations; plus NIH-TeneoBio and Basilea

...subsets linked to metastasis In a study published in Nature Communications , a team from Institut Curie...
...KGFR; CD332) - Fibroblast growth factor receptor 2; TGFβ - Transforming growth factor β BioCentury Staff TeneoBio Inc. Institut Curie Institut...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...20 years in several leadership roles. French immunotherapy play Stimunity S.A.S., which spun out of Institut Curie...
...GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Harvard University, Cambridge, Mass. Hope Medicine Inc., Beijing, China Institut Curie...
BioCentury | Jan 23, 2018
Distillery Therapeutics

Cancer

...online Nov. 14, 2017 doi:10.1016/j.celrep.2017.10.076 CONTACT: Franck Bourdeaut, Institut Curie Research Center, Paris, France email: franck.bourdeaut@curie.fr Winnie Pong Institut Curie Potassium...
BioCentury | Nov 6, 2017
Preclinical News

Team identifies new target for MM CAR T therapy

...in clinical trials. Celyad S.A. (Euronext:CYAD; NASDAQ:CYAD) partnered with Ono Pharmaceutical Co. Ltd. (Tokyo:4528) and Institut Curie...
...beta(7), in Phase III trials for Crohn's disease and ulcerative colitis UC). Allison Johnson AUTO2 etrolizumab Autolus Therapeutics plc Celyad S.A. Institut Curie Ono...
BioCentury | Oct 27, 2017
Company News

Institut Curie, Pierre Fabre partner to develop cancer immunotherapies

...The Institut Curie (Paris, France) and the Laboratoires Pierre Fabre S.A. (Castres, France) entered a renwable, one-year...
...the deal. Institut Curie , Paris, France Laboratoires Pierre Fabre S.A. , Castres, France Business: Cancer Alicia Parker Institut Curie Pierre...
BioCentury | Aug 3, 2017
Tools & Techniques

Click bait

...consider radioactivity." Paola Grandi, Cellzome GSK joined with academic collaborators from University of Melbourne and Institut Curie...
...Figure: Pick your click Researchers from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), the University of Melbourne and Institut Curie...
...and Institutions Mentioned European Molecular Biology Laboratory, Heidelberg, Germany GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Institut Curie...
BioCentury | Jun 29, 2017
Product R&D

Drop the MIC

...a strategy pursued by Celyad S.A. , which partnered with Ono Pharmaceutical Co. Ltd. and Institut Curie...
...Euronext:CYAD; NASDAQ:CYAD), Mont-Saint-Guibert, Belgium Courier Therapeutics Inc., Houston, Texas Innate Pharma S.A. (Euronext:IPH), Marseille, France Institut Curie...
...Writer American Association for Cancer Research CanCure LLC Celyad S.A. Centre for Drug Research and Development Courier Therapeutics Inc. Innate Pharma S.A. Institut Curie Novelogics...
BioCentury | Apr 4, 2016
Company News

Celyad, Institut Curie deal

...Celyad and Institut Curie partnered to develop Celyad’s NKR-T program. NKR-2 , which comprises autologous chimeric antigen...
...Phase I data in mid-2016. Institut Curie plans to launch the Center for Cancer Immunotherapy of Institut Curie...
...financial terms, and the institute did not respond to inquiries. Celyad S.A. (Euronext:CYAD;NASDAQ:CYAD), Mont-Saint-Guibert, Belgium Institut Curie...
BioCentury | Nov 2, 2015
Emerging Company Profile

Targeted disruption

...Angelita Rebollo University collaborators: Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Curie...
BioCentury | Jul 23, 2015
Distillery Techniques

Techniques: Activating mutations in the Ras-MAP kinase (MAPK) pathway to predict relapsed neuroblastoma response to MEK inhibitors

...MEK1 MAP kinase kinase 2 MAP2K2 MEK2 Exelixis Inc. Genentech Inc. Roche Array BioPharma Inc. Institut Curie...
Items per page:
1 - 10 of 52
BioCentury | Jan 24, 2020
Preclinical News

Jan. 23 Preclinical Quick Takes: Metastasis-associated cancer-associated fibroblast populations; plus NIH-TeneoBio and Basilea

...subsets linked to metastasis In a study published in Nature Communications , a team from Institut Curie...
...KGFR; CD332) - Fibroblast growth factor receptor 2; TGFβ - Transforming growth factor β BioCentury Staff TeneoBio Inc. Institut Curie Institut...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...20 years in several leadership roles. French immunotherapy play Stimunity S.A.S., which spun out of Institut Curie...
...GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Harvard University, Cambridge, Mass. Hope Medicine Inc., Beijing, China Institut Curie...
BioCentury | Jan 23, 2018
Distillery Therapeutics

Cancer

...online Nov. 14, 2017 doi:10.1016/j.celrep.2017.10.076 CONTACT: Franck Bourdeaut, Institut Curie Research Center, Paris, France email: franck.bourdeaut@curie.fr Winnie Pong Institut Curie Potassium...
BioCentury | Nov 6, 2017
Preclinical News

Team identifies new target for MM CAR T therapy

...in clinical trials. Celyad S.A. (Euronext:CYAD; NASDAQ:CYAD) partnered with Ono Pharmaceutical Co. Ltd. (Tokyo:4528) and Institut Curie...
...beta(7), in Phase III trials for Crohn's disease and ulcerative colitis UC). Allison Johnson AUTO2 etrolizumab Autolus Therapeutics plc Celyad S.A. Institut Curie Ono...
BioCentury | Oct 27, 2017
Company News

Institut Curie, Pierre Fabre partner to develop cancer immunotherapies

...The Institut Curie (Paris, France) and the Laboratoires Pierre Fabre S.A. (Castres, France) entered a renwable, one-year...
...the deal. Institut Curie , Paris, France Laboratoires Pierre Fabre S.A. , Castres, France Business: Cancer Alicia Parker Institut Curie Pierre...
BioCentury | Aug 3, 2017
Tools & Techniques

Click bait

...consider radioactivity." Paola Grandi, Cellzome GSK joined with academic collaborators from University of Melbourne and Institut Curie...
...Figure: Pick your click Researchers from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), the University of Melbourne and Institut Curie...
...and Institutions Mentioned European Molecular Biology Laboratory, Heidelberg, Germany GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Institut Curie...
BioCentury | Jun 29, 2017
Product R&D

Drop the MIC

...a strategy pursued by Celyad S.A. , which partnered with Ono Pharmaceutical Co. Ltd. and Institut Curie...
...Euronext:CYAD; NASDAQ:CYAD), Mont-Saint-Guibert, Belgium Courier Therapeutics Inc., Houston, Texas Innate Pharma S.A. (Euronext:IPH), Marseille, France Institut Curie...
...Writer American Association for Cancer Research CanCure LLC Celyad S.A. Centre for Drug Research and Development Courier Therapeutics Inc. Innate Pharma S.A. Institut Curie Novelogics...
BioCentury | Apr 4, 2016
Company News

Celyad, Institut Curie deal

...Celyad and Institut Curie partnered to develop Celyad’s NKR-T program. NKR-2 , which comprises autologous chimeric antigen...
...Phase I data in mid-2016. Institut Curie plans to launch the Center for Cancer Immunotherapy of Institut Curie...
...financial terms, and the institute did not respond to inquiries. Celyad S.A. (Euronext:CYAD;NASDAQ:CYAD), Mont-Saint-Guibert, Belgium Institut Curie...
BioCentury | Nov 2, 2015
Emerging Company Profile

Targeted disruption

...Angelita Rebollo University collaborators: Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Curie...
BioCentury | Jul 23, 2015
Distillery Techniques

Techniques: Activating mutations in the Ras-MAP kinase (MAPK) pathway to predict relapsed neuroblastoma response to MEK inhibitors

...MEK1 MAP kinase kinase 2 MAP2K2 MEK2 Exelixis Inc. Genentech Inc. Roche Array BioPharma Inc. Institut Curie...
Items per page:
1 - 10 of 52